Frontline BioVentures is a private equity general partner firm with offices in China, Hong Kong and United States.
Hua Medicine, a China-based clinical-stage company developing therapies, closed around $50m in Series C financing from Venrock and others.
Frontline BioVentures has led an undisclosed Series A funding round for Sino Health, a Chinese healthcare investment holding platform.
Innovent Biologics, a Shangai, China-based biopharmaceutical company, has raised $100m in Series C financing from Legend Capital and others.
Read more news concerning Frontline BioVentures
A sampling of Frontline BioVentures portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?